Table 1.
Step Ensemble | Timestep (fs) | Length (ns) | Restraint force constant (kcal/mol/Å2) | ||||
---|---|---|---|---|---|---|---|
Stage 1. Initial equilibration | BBa | SC+XWata | Lipisb | BWatc | |||
1 | NVT | 1 | 0.05 | 10.0 | 5.0 | 2.5 | 2.5 |
2 | NVT | 2 | 0.05 | 5.0 | 5.0 | 2.5 | 2.5 |
3 | NPT | 2 | 0.1 | 5.0 | 5.0 | 1.0 | 1.0 |
4 | NPT | 2 | 0.1 | 5.0 | 2.5 | 0.5 | 0.5 |
5 | NPT | 2 | 0.1 | 2.5 | 2.5 | 0.1 | 0.1 |
6 | NPT | 2 | 0.1 | 2.5 | 2.5 | 0.0 | 0.0 |
Stage 2. Membrane equilibration | BB + SC | ||||||
1 | NVT | 2 | 0.2 | 2.5 | |||
2 | NPT | 2 | 100 | 2.5 | |||
Stage 3. CpHMD equilibration | BB + SC | ||||||
1 | NVT | 2 | 0.1 | 1.0 | |||
2 | NPT | 2 | 0.1 | 1.0 | |||
3 | NPT | 2 | 0.8 | 0.0 |
BB and SC refer to protein backbone and side chain heavy atoms, respectively. XWat and BWat refer to crystallographic and bulk water oxygen atoms, respectively.
Lipid heavy atoms are restrained with a planar harmonic potential to ensure that lipid tails are close to the bilayer center (−5 Å < Z < 5 Å), and lipid head groups are close to the bilayer surface (Z = ±19 Å for POPE).
A planar harmonic restraint is applied to the bulk water oxygen atoms to keep them away from the membrane hydrophobic region.